Journal of Molecular Oncology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Molecular Oncology Research (2023) Volume 7, Issue 3

Treatment Options for Prostate Cancer: From Active Surveillance to Surgery

Fuxiang Fang*

Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China

*Corresponding Author:
Fuxiang Fang
Department of Radiation Oncology and Medical Oncology
Zhongnan Hospital of Wuhan University, Wuhan, China
E-mail: fxngfang@gmail.com

Received: 24-Feb-2023, Manuscript No. AAMOR-23-90260; Editor assigned: 28-Feb-2023, PreQC No. AAMOR-23-90260(PQ); Reviewed: 14-Mar-2023, QC No AAMOR-23-90260; Revised: 20-Mar-2023, Manuscript No. AAMOR-23-90260(R); Published: 27-Mar-2023, DOI:10.35841/aamor-7.3.173

Citation: Fang F. Treatment options for prostate cancer: From active surveillance to surgery. J Mol Oncol Res. 2023;7(3):173

Visit for more related articles at Journal of Molecular Oncology Research

Abstract

Prostate cancer is a common type of cancer that affects men, particularly those over 50 years old. There are several treatment options available for prostate cancer, ranging from active surveillance to surgery. Active surveillance involves monitoring the cancer to see if it grows or changes over time, while surgery involves the removal of the prostate gland. Other treatment options include radiation therapy, hormone therapy, and chemotherapy. The choice of treatment depends on several factors, including the stage and grade of the cancer, the age and overall health of the patient, and the patient's preferences. This article will discuss the different treatment options for prostate cancer, their benefits and risks, and factors to consider when choosing a treatment.

Keywords

Prostate cancer, Surveillance of surgery, Radiation Therapy, Hormone Therapy.

Introduction

Prostate cancer is a type of cancer that affects the prostate gland, which is a small gland located in the male reproductive system. Prostate cancer is one of the most common types of cancer in men, with over 240,000 new cases diagnosed each year in the United States alone. While prostate cancer can be a serious and life-threatening condition, the good news is that it is often slowgrowing and can be effectively treated if caught early.

Treatment Options

There are several treatment options available for prostate cancer, each with its own benefits and risks. The choice of treatment depends on several factors, including the stage and grade of the cancer, the age and overall health of the patient, and the patient's preferences [1].

Active Surveillance

Active surveillance, also known as watchful waiting, involves monitoring the cancer to see if it grows or changes over time. This option is often recommended for men with low-risk prostate cancer that is unlikely to spread and cause harm. During active surveillance, the patient will have regular check-ups with their doctor to monitor the cancer's growth and may undergo additional tests such as biopsies and imaging studies. If the cancer begins to grow or change, other treatment options may be considered.

Surgery

Surgery involves the removal of the entire prostate gland and is a common treatment option for prostate cancer. There are two main types of surgery: radical prostatectomy and laparoscopic prostatectomy. Radical prostatectomy involves the removal of the entire prostate gland, as well as nearby lymph nodes and tissues. Laparoscopic prostatectomy is a minimally invasive procedure that uses small incisions and a camera to remove the prostate gland [2].

Radiation Therapy

Radiation therapy involves using high-energy radiation to kill cancer cells. There are two main types of radiation therapy: external beam radiation therapy and brachytherapy. External beam radiation therapy involves using a machine to deliver radiation to the prostate gland from outside the body, while brachytherapy involves placing small radioactive pellets directly into the prostate gland [3].

Hormone Therapy

Hormone therapy involves using medications to block the production or action of male hormones, such as testosterone, which can stimulate the growth of prostate cancer cells. Hormone therapy may be used alone or in combination with other treatments, such as radiation therapy or surgery [4].

Benefits and Risks

Each treatment option for prostate cancer has its own benefits and risks. For example, surgery has the potential to cure the cancer and remove it completely, but it can also cause side effects such as urinary incontinence and erectile dysfunction. Radiation therapy can also cure the cancer and is less invasive than surgery, but it can also cause side effects such as fatigue and skin irritation. Hormone therapy can be effective in slowing down the growth of the cancer, but it can also cause side effects such as hot flashes and loss of bone density. Chemotherapy is typically reserved for advanced cases of prostate cancer and can cause side effects such as nausea, hair loss, and fatigue.

It's important for patients to discuss the benefits and risks of each treatment option with their doctor to make an informed decision about their care. In addition, patients should also consider their personal preferences and lifestyle when choosing a treatment [5].

Conclusion

Prostate cancer is a common type of cancer that affects men, particularly those over 50 years old. There are several treatment options available for prostate cancer, ranging from active surveillance to surgery. Each treatment option has its own benefits and risks, and the choice of treatment depends on several factors, including the stage and grade of the cancer, the age and overall health of the patient, and the patient's preferences. It's important for patients to discuss their options with their doctor and make an informed decision about their care. With proper treatment, many men with prostate cancer can go on to live long and healthy lives.

References

  1. Song K, Backs J, McAnally J, et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell. 2006;125(3):453-66.

    2. Indexed at, Google scholar, Cross Ref

  2. Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin. 2015;62(1):11-25.

    3. Indexed at, Google scholar, Cross Ref

  3. Spycher BD, Lupatsch JE, Zwahlen M, et al. Background ionizing radiation and the risk of childhood cancer: a census-based nationwide cohort study. Environ Health Perspect. 2015;123(6):622-8.

    4. Indexed at, Google scholar, Cross Ref

  4. Stecca C, Gerber GB. Adaptive response to DNA-damaging agents: a review of potential mechanisms. Biochem Pharmacol. 1998;55(7):941-51.

    5. Indexed at, Google scholar, Cross Ref

  5. Stoyanova T, Roy N, Kopanja D, et al. DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci. 2009 Jun;106(26):10690-5.

    6. Indexed at, Google scholar, Cross Ref

Get the App